How do startups decide between trade secret and patent protection? What does the analysis look like? Sandy Chan, Executive Director & General Counsel at IP Counsel Cafe speaks with Kevin Brown, Vice President of IP at Recursion Pharmaceuticals, a clinical-stage biotechnology company that combines experimental biology and automation with artificial intelligence to discover potential drugs; and Stephanie Southwick, Legal Counsel and Investment Manager at Omni Bridgeway, a global leader in dispute resolution finance.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Sandy Chan. Innehållet i podden är skapat av Sandy Chan och inte av, eller tillsammans med, Poddtoppen.